Ozobax - baclofen oral solution
Go to Patient Site

Savings & Support

Savings for Your Patients

Ozobax Savings Card

 

Your Patients Can Save With The Ozobax Patient Savings Card
They pay as little as $15 for 30 days*

*Limitations apply. Reimbursement limited to $200 per month.

 

 

 

Patient Instructions:

  • Get a valid prescription for OZOBAX (baclofen) Oral Solution 5mg/5mL. Ask your doctor if OZOBAX is right for you.
  • Ask your doctor for your OZOBAX Patient Savings Card.
  • Fill your prescription by taking OZOBAX Patient Savings Card and your prescription to your pharmacy.
  • Many eligible commercially insured patients will receive their prescription for $15.*

*Program eligibility and restrictions apply. This offer is only valid for Ozobax Oral Solution 5mg/5mL, manufactured for Metacel Pharmaceuticals, LLC. No substitutions permitted.

If you need an OZOBAX Patient Savings Card for your patient, please call 833-469-6229.

 

Support and Information

Your patients can find additional support and information about living with multiple sclerosis here.

National Multiple Sclerosis Society
nationalmssociety.orgMultiple Sclerosis Foundation
msfocus.org

Multiple Sclerosis Association of America
mymsaa.orgCan Do Multiple Sclerosis
cando-ms.org

Additional support and information about living with spinal cord injury can be found here.

National Spinal Cord Injury Association
spinalcord.org
Christopher and Dana Reeve Paralysis Resource Center
paralysis.org

Indications and Usage

OZOBAX® is indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.

OZOBAX may also be of some value in patients with spinal cord injuries and other spinal cord diseases.

Limitations of Use: OZOBAX is not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders.

Important Safety Information

OZOBAX® is contraindicated in patients with hypersensitivity to baclofen.

Abrupt discontinuation of baclofen has resulted in serious adverse reactions including death; therefore, reduce the dosage slowly when OZOBAX is discontinued.

Neonatal withdrawal symptoms can occur; gradually reduce the dosage and discontinue OZOBAX before delivery.

OZOBAX can cause drowsiness and sedation. Patients should avoid the operation of machinery until they know how the drug affects them. Advise patients that the central nervous system effects of OZOBAX may be additive to those of alcohol and other CNS depressants.

OZOBAX should be used with caution in patients who have had a stroke.

OZOBAX can cause exacerbation of the following: psychotic disorders, schizophrenia, or confusional states; autonomic dysreflexia; epilepsy. Use with caution in patients with these conditions.

The most common adverse reactions (>1%) in patients treated with baclofen for spasticity are drowsiness, dizziness, weakness, nausea, confusion, hypotension, headache, insomnia, constipation, urinary frequency and fatigue.

You are encouraged to report adverse reactions to Metacel Pharmaceuticals, LLC at 1-833-469-6229 or to the FDA:  www.fda.gov/medwatch or 1-800-FDA-1088.

Please see the accompanying Full Prescribing Information.